The Japanese Journal of Pharmacology · 1998 · 28 citations · 11 references
MedicineMedicinal ChemistryPharmacologyMolecular PharmacologyNeurochemistryNeuropharmacologyLigand BindingMonoamine NeurochemistryReceptor PharmacologySerotonergic Pharmacology5-Hydroxytryptamine 3 Receptor Antagonists5-Hydroxytryptamine Receptor PharmacologyCompetitive SaturationSaturationSerotonin AgonistsSerotonin Receptor Pharmacology
Characteristics of the binding of [3H]ramosetron to cloned human 5-hydroxytryptamine3 (5-HT3) receptors were investigated and directly compared to those of [3H]granisetron binding. Saturation studies revealed that [3H]ramosetron labeled more sites with high affinity (Kd=0.15+/-0.01 nM, Bmax =653 +/- 30 fmol/mg protein) than [3H]granisetron (Kd=1.17+/-0.25 nM, Bmax=427+/-43 fmol/mg protein). Kinetic studies revealed that dissociation of [3H]ramosetron was slower than that of [3H]granisetron. These results suggest that ramosetron is a highly potent 5-HT3-receptor antagonist.
11
5-HT3 receptors are membrane ion channels
V. A. Derkach, Annmarie Surprenant, R A North · Nature · 1989 · 629 citations
Medicine, Pharmacology, Physiology +14